Conteúdo

Tipo de Material

Tipo

Instituições

Filtro de Materiais por Instituição

Categorias

Filtro de NOVA Categorias

Idioma

Filtro por Idioma

Real-world progression-free survival of CDK4/6 inhibitors plus anaromatase inhibitor in HR-positive/HER2-negative metastatic breast cancerin United States routine clinical practice

Artigo
Breast Breaking News
Mastologia
Inglês

Real‑World Application of Alliance ACOSOG Z11102: HowMany Patients Can be Spared Mastectomy?

Artigo
Breast Breaking News
Inglês

Artificial Intelligence in Symptomatic Carotid Plaque Detection: A Narrative Review

Artigo
Carótida Online
Cardiologia
29/03/2023
Inglês

The association between young age atmetastatic breast cancer diagnosis andoverall survival in the EMBRACE study

Artigo
Breast Breaking News
Mastologia
Inglês

GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity

Artigo
Breast Breaking News
Mastologia
24/09/2025
Inglês

Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer

Artigo
Breast Breaking News
Mastologia
13/08/2025
Inglês

Iodine Seed−Marking Protocol for Response-Guided Axillary TreatmentAfter Systemic Therapy for Node-Positive Breast Cancer

Artigo
Breast Breaking News
Mastologia
28/08/2025
Inglês

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay

Artigo
Breast Breaking News
Mastologia
15/09/2025
Inglês

Biology is Queen: The Oncotype DX 21‑Gene Recurrence ScoreHas Stronger Prognostic Ability than Lymph Node Burdenfor Patients with Breast Cancer

Artigo
Breast Breaking News
Mastologia
20/08/2025

Patritumab deruxtecan in HR+HER2−advanced breast cancer: a phase 2 trial

Artigo
Breast Breaking News
Mastologia
31/03/2025

Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery

Artigo
Breast Breaking News

A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients

Artigo
Breast Breaking News
Mastologia
Carregar mais

Receba nossa

Programação Semanal

Facebook Instagram Linkedin

Quem Somos

Como Produzir

Depoimentos

Fale Conosco

Termos e Condições

Lives
Cursos
Vídeos
Podcasts

Instituições
Profissionais
Grupos de estudo
Impulso

Desenvolvido por makadu.group

Precisa de ajuda? Nos chame no chat da página!

Carrinho de compras